Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
BioLineRx Q4 2025 and Full Year 2025 Earnings Call - GLIX1 IND Approved; First-in-Human GBM Trial Launch Imminent
BioLineRx pivoted decisively in 2025, with GLIX1 emerging as the new lead asset. The Hemispherian IND was cleared, orphan designations were secured in the U.S. and EU, and a first-in-human phase I/II-...
- GLIX1 IND approved and cleared for first-in-human trials, with company on track to initiate the phase I/II-A GBM study by the end of the month.
- GLIX1 received orphan drug designation from both the FDA and the European Medicines Agency, which can accelerate review and provide market exclusivity incentives.
- Phase I portion will enroll up to 30 recurrent or progressive GBM and high-grade glioma patients, primary objective is safety and determination of maximum tolerated or recommended dose; data from phase I expected in the first half of next year according to management.
- +14 more takeaways
Gamehaus Q2 FY2026 Earnings Call - Profitability Rebound While Topline Is Tactically Trimmed for Higher-Quality Growth
Gamehaus reported revenue of $26.3 million in Q2 FY2026, a 7.8% year-over-year decline, but delivered a clearproof of its efficiency push: operating margin expanded to 3.3% from 0.8% and net income ro...
- Total revenue for Q2 FY2026 was $26.3 million, down 7.8% year-over-year from $28.5 million.
- Net income rose approximately 151% year-over-year to about $0.9 million.
- Operating income improved to $0.9 million, driving operating margin to 3.3% versus 0.8% a year ago.
- +16 more takeaways
CuriosityStream Q4 2025 Earnings Call - Licensing set to eclipse subscriptions in 2026 as AI deals accelerate
CuriosityStream closed 2025 with clear momentum. Full year revenue rose 40% to $71.7 million, adjusted free cash flow grew 46% to $13.9 million, and Q4 revenue was $19.2 million, up 36% year over year...
- Full year 2025 revenue rose 40% year over year to $71.7 million, with Q4 revenue up 36% to $19.2 million.
- Adjusted free cash flow for 2025 increased 46% to $13.9 million, and Q4 adjusted free cash flow was $4.3 million.
- CuriosityStream reported its fourth sequential quarter of positive adjusted EBITDA, with Q4 adjusted EBITDA of $1.1 million and full-year adjusted EBITDA of $8.2 million.
- +12 more takeaways
Cemig Fourth Quarter 2025 Earnings Call - Record BRL 6.6bn CapEx Funded by Strong EBITDA and Aaa Rating
Cemig closed 2025 with a clear message, cashing in strong regulated cash flow to finance a record investment surge. Recurring EBITDA was BRL 7.3 billion, full EBITDA BRL 8.3 billion, and the company i...
- Recurring EBITDA BRL 7.3 billion in 2025, full EBITDA BRL 8.3 billion including non-recurring items.
- Record investments of BRL 6.6 billion in 2025, concentrated in distribution, generation and transmission.
- Cemig has nearly BRL 10 billion of distribution investments already built but to be recognized in the 2028 tariff review.
- +14 more takeaways
Westwater Resources Q4 2025 Earnings Call - Kellyton 12 Months From Production if Remaining $50M Secured
Westwater says it is a step away from commercial U.S. battery-grade graphite. The company reports $50 million cash on hand, a phase one Kellyton capex target of $245 million that includes an untouched...
- Company filed 2025 Form 10-K and posted press release and investor presentation to its website.
- Management says Kellyton phase one capex remains approximately $245 million, including an untouched $20 million contingency, after optimization efforts.
- Westwater reports approximately $50 million cash on hand at year-end 2025, and states roughly $50 million of additional capital is needed to substantially complete Kellyton phase one.
- +12 more takeaways
Ermenegildo Zegna Group FY 2025 Earnings Call - Resilient DTC lifts margins despite wholesale and Middle East headwinds
Zegna reported FY2025 revenues of EUR 1,917 million, down 1.5% reported but up 1.1% organically, with a 67.5% gross margin and adjusted EBIT of EUR 163 million (EUR 173 million before a EUR 10 million...
- FY2025 headline numbers: revenues EUR 1,917m (-1.5% reported, +1.1% organic), gross margin 67.5%, adjusted EBIT EUR 163m (EUR 173m ex EUR 10m Saks provision), net profit EUR 109.5m (+20%).
- Direct-to-consumer drove margin expansion, DTC now 82% of branded revenues versus 78% a year ago, and was a primary reason gross margin improved by c.90 basis points.
- Saks Global Chapter 11 hit results, with a total EUR 10m provision recorded across the group; management allocates approximately EUR 3m to Zegna, EUR 2m to Thom Browne, and EUR 5m to Tom Ford.
- +14 more takeaways
Cellectis Q4 & FY 2025 Earnings Call - Lasme-cel posts 100% ORR in target Phase 2 population, pivotal launched
Cellectis framed 2025 as a year of survival turned momentum. The company touted lasme-cel, its allogeneic CD22 CAR-T, which showed a 100% overall response rate in the target Phase 2 population (9 pati...
- Lasme-cel (CD22 allogeneic CAR-T) achieved 100% ORR in the target Phase 2 population, converting all 9 patients to transplant eligibility, with 7 of 9 receiving stem cell transplant by data cut-off.
- At the recommended Phase 2 dose, lasme-cel showed an 83% ORR and a CR/CRi rate of 42% across Phase 1; among CR/CRi patients, 80% achieved MRD negative status.
- Pivotal Phase 2 BALLI-02 for lasme-cel has been initiated, with the first interim analysis of 40 patients expected in Q4 2026, using an 8-week composite read to select alemtuzumab dose.
- +12 more takeaways
BitFuFu Inc. Full Year 2025 Earnings Call - Cloud mining drives revenue while treasury stacking and liquidity stay prioritized
BitFuFu leaned into its hybrid cloud and self-mining platform in 2025 and emerged with revenue growth, a larger cloud-mining mix, and a deliberate emphasis on liquidity amid a volatile Bitcoin cycle. ...
- Total revenue for full year 2025 was about $475.6–475.8 million, up modestly from 2024.
- Cloud mining was the engine, generating $350.6 million, up 29.3% year-over-year and representing ~74% of revenue.
- Self-mining revenue collapsed to $63.1 million from $157.5 million in 2024, reflecting weaker hash price and higher network difficulty.
- +12 more takeaways
FedEx Corporation Q3 FY2026 Earnings Call - FEC strength and Network 2.0 offset Freight weakness, company raises FY26 adjusted EPS
FedEx posted a stronger-than-expected Q3, driven by a resurgent FedEx Express and ground package business, disciplined pricing, and early Network 2.0 wins that made this the company’s most profitable ...
- Consolidated revenue rose 8% year-over-year, with adjusted operating income up 7% and adjusted EPS up 16% in Q3.
- FedEx Express and ground (FEC) led the quarter, with FEC revenue up 10% and adjusted operating margin expanding by 50 basis points, driving an 18% increase in FEC adjusted operating income.
- Management raised FY2026 adjusted EPS to $19.30 to $20.10 from the prior $17.80 to $19.00 range, citing stronger FEC performance and transformation progress.
- +12 more takeaways
Firefly Aerospace Q4 2025 Earnings Call - Record Revenue, SciTec Buy, and Alpha Block II Set Stage for Aggressive 2026 Growth
Firefly closed a transformational 2025: record revenue of $159.9 million, a successful IPO, and the strategic acquisition of SciTec that immediately broadened the company into operational defense soft...
- Firefly reported record 2025 revenue of $159.9 million, a 163% year-over-year increase, and Q4 revenue of $57.7 million, the company’s highest quarter to date.
- Management framed 2025 as transformational: a successful IPO, the first commercial moon landing with Blue Ghost Mission 1, and the close of the SciTec acquisition.
- SciTec acquisition closed in Q4, paid $277.4 million net of cash acquired, immediately adding government software contracts and operational capabilities, notably the FORGE missile warning system.
- +15 more takeaways